Is Huada Gene a monster stock or a genuine one? For this question, many people must have a question in their minds. I don't know if there is an exact answer today. Once its stock price reached 256 yuan per share at its highest, and its market value exceeded 100 billion yuan, it was called the Tencent of the gene world.
In the 19 years since its founding, the glory and controversy behind BGI have always No less. I still remember that in May of this year, Wang Jian, the chairman of BGI Gene, once stated on a forum that BGI’s employees will not be capped at the age of 100. He also imposed three strict disciplines on employees.
The original intention was to show BGI’s emphasis on human health and its own technology. As a result, I didn't expect that after this remark, BGI's stock was affected the next day, not increasing but decreasing.
In June, BGI was reported by a letter from its partners. The Chinese whistleblower Nanjing Changjian Company accused BGI of "defrauding state-owned assets" and other illegal activities. BGI suddenly fell into the "reporting door."
Problems that arise in cooperation should be common to most companies, but the measures generally taken are solved privately. Rarely, like Nanjing Changjian, they will directly report the other party.
So what kind of grievances and hatred did they experience that led to such a trouble?
Two years ago, in April 2016, BGI and Nanjing Changjian Company signed a cooperation agreement to prepare for the establishment of the National Gene Bank Cell Center Jiangsu Operation Center. And preparations for the construction, and later due to various difficulties, this cooperation was not completed as expected.
It stands to reason that the cooperation has not been reached, and the two parties should immediately terminate the cooperation relationship, but the development of the future It's not that simple.
According to the arguments of the two parties, BGI accused that Nanjing Changjian Company has been carrying out related activities in the name of "National Gene Bank Cell Center Jiangsu Operation Center", which has seriously damaged the national gene bank's Reputation has misled the public. In May 2017 and January 2018, the "Infringement Notification Letter" and the "Contract Termination Notice" were sent to Nanjing Changjian Company respectively.
Subsequently, Nanjing Changjian Company also stated that BGI had unilaterally terminated the cooperation. It also communicated with BGI for 5 months to no avail, and its own company was also seriously affected by the termination of the contract. influences.
On the last day of May, Nanjing Changjian Company collected the "land of state-owned assets". Evidence such as "pseudoscience" brought BGI to court. In the letter, Nanjing Changjian Company also emphatically mentioned that the chief scientist of BGI has only a high school diploma, which is completely pseudoscience.
Affected by this incident, BGI's stock has taken a sharp turn, and the stock price in the past month has fallen from the original 126.26 yuan to 96.41 yuan.
Now Huada Gene can't sit still, and even a media conference was held yesterday. Large group CEO Xu Xun responded to the projects alleged by Nanjing Changjian Company one by one.
From the original market value of 100 billion to the present, it has only been more than a year. The market value of BGI Cut more than half of it, from the boss of the biotech circle that was initially favored by people, to now it is questioned about its scientific professionalism.
In the process of development, BGI can only say that it did not seize its advantages in time. In the future, it is hard to say how it will develop.